Regenxbio Stock Beneish M Score

RGNX Stock  USD 8.24  0.12  1.44%   
This module uses fundamental data of Regenxbio to approximate the value of its Beneish M Score. Regenxbio M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Regenxbio Piotroski F Score and Regenxbio Altman Z Score analysis.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.
  
At this time, Regenxbio's Net Debt is fairly stable compared to the past year. Debt To Equity is likely to rise to 0.33 in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 54.5 M in 2025. At this time, Regenxbio's Tangible Book Value Per Share is fairly stable compared to the past year. Shareholders Equity Per Share is likely to rise to 7.59 in 2025, whereas Price To Sales Ratio is likely to drop 4.36 in 2025.
At this time, Regenxbio's M Score is unavailable. The earnings manipulation may begin if Regenxbio's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Regenxbio executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Regenxbio's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.63
Beneish M Score - Unavailable
Elasticity of Receivables

0.69

Focus
Asset Quality

0.98

Focus
Expense Coverage

0.5

Focus
Gross Margin Strengs

1.42

Focus
Accruals Factor

0.5

Focus
Depreciation Resistance

1.0

Focus
Net Sales Growth

1.32

Focus
Financial Leverage Condition

0.65

Focus

Regenxbio Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Regenxbio's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables18.7 M20.5 M
Significantly Down
Slightly volatile
Total Revenue110 M83.3 M
Significantly Up
Slightly volatile
Total Assets489.1 M466 M
Sufficiently Up
Slightly volatile
Total Current Assets288.4 M278 M
Sufficiently Up
Slightly volatile
Non Current Assets Total200.7 M188 M
Notably Up
Slightly volatile
Property Plant Equipment249.7 M237.8 M
Sufficiently Up
Slightly volatile
Selling General Administrative50.8 M76.6 M
Way Down
Slightly volatile
Total Current Liabilities61.8 M103.2 M
Way Down
Slightly volatile
Non Current Liabilities Total101.1 M103.1 M
Fairly Down
Slightly volatile
Short Term Debt5.6 M7.9 M
Way Down
Slightly volatile
Short Term Investments170.5 M177.2 M
Sufficiently Down
Slightly volatile
Long Term Investments9.7 M10.2 M
Notably Down
Slightly volatile
Gross Profit Margin0.850.5972
Significantly Up
Slightly volatile

Regenxbio Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Regenxbio's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Regenxbio in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Regenxbio's degree of accounting gimmicks and manipulations.

About Regenxbio Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

17.03 Million

At this time, Regenxbio's Depreciation And Amortization is fairly stable compared to the past year.

Regenxbio Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Regenxbio. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
202020212022202320242025 (projected)
Net Receivables43.0M32.4M28.1M26.3M20.5M18.7M
Total Revenue154.6M470.3M112.7M90.2M83.3M110.0M
Total Assets708.2M1.1B833.3M574.0M466.0M489.1M
Total Current Assets531.2M518.8M416.0M335.0M278.0M288.4M
Net Debt(265.8M)(258.5M)(2.2M)54.8M24.5M25.7M
Short Term Debt5M3.5M12.0M7.1M7.9M5.6M
Operating Income(119.2M)160.0M(262.9M)(268.1M)(233.3M)(221.7M)
Investments147.3M(322.5M)(11.9M)183.7M103.4M108.6M

Regenxbio ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Regenxbio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Regenxbio's managers, analysts, and investors.
Environmental
Governance
Social

About Regenxbio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Regenxbio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Regenxbio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Regenxbio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.